Search

Your search keyword '"Natasha Burke"' showing total 55 results
Start Over Author "Natasha Burke"
55 results on '"Natasha Burke"'

51. Timing of Initial Administration of Prophylaxis Against Deep Vein Thrombosis in Patients Following Hip or Knee Surger

Author

Andrew F. Mah, Graham F. Pineo, Russell D. Hull, and Natasha Burke

Subjects
Pulmonary and Respiratory Medicine, medicine.medical_specialty, business.industry, Deep vein, Hip region, Critical Care and Intensive Care Medicine, medicine.disease, Thrombosis, Surgery, medicine.anatomical_structure, Knee surgery, medicine, In patient, Cardiology and Cardiovascular Medicine, business, Administration (government)
Published
2003
Full Text
View/download PDF

52. A review of the cost of cardiovascular disease

Author

Daria O'Reilly, Marie DesMeules, Morgan E. Lim, Natasha Burke, James M. Bowen, Wei Luo, Ron Goeree, and Jean-Eric Tarride

Subjects
Heart Failure, Gerontology, Canada, medicine.medical_specialty, Health economics, business.industry, Australia, Canadian studies, Disease, United States, Europe, Stroke, Cardiovascular Diseases, Economic cost, Environmental health, Hypertension, Health care, medicine, Humans, Health Outcomes/Public Policy, Outcomes research, Cardiology and Cardiovascular Medicine, business, Developed country, Health policy
Abstract

In Canada, 74,255 deaths (33% of all deaths) in 2003 were due to cardio-vascular disease (CVD). As one of the most costly diseases, CVD represents a major economic burden on health care systems. The purpose of the present study was to review the literature on the economic costs of CVD in Canada and other developed countries (United States, Europe and Australia) published from 1998 to 2006, with a focus on Canada. Of 1656 screened titles and abstracts, 34 articles were reviewed including six Canadian studies and 17 American studies. While considerable variation was observed among studies, all studies indicated that the costs of treating CVD-related conditions are significant, outlining a convincing case for CVD prevention programs.

53. PIN34 INTRANASAL LIVE ATTENUATED (LAIV) VERSUS INJECTABLE INACTIVATED (TIV) INFLUENZA VACCINE FOR CHILDREN AND ADOLESCENTS: A CANADIAN COST EFFECTIVENESS ANALYSIS

Author

Feng Xie, C. von Keyserlingk, Daria O'Reilly, Natasha Burke, Ron Goeree, and Jean-Eric Tarride

Subjects
Pediatrics, medicine.medical_specialty, business.industry, Influenza vaccine, Health Policy, Immunology, Public Health, Environmental and Occupational Health, Medicine, Live attenuated influenza vaccine, Nasal administration, Cost-effectiveness analysis, business
Full Text
View/download PDF

54. PCV50 Hospital Costs Associated with Atrial Fibrillation in Canada

Author

Ron Goeree, Robert Hopkins, L. Sauriol, Natasha Burke, Jeff S. Healey, Jean-Eric Tarride, Paul Dorian, and Daria O'Reilly

Subjects
Disease specific, medicine.medical_specialty, business.industry, Internal medicine, Health Policy, Emergency medicine, medicine, Cardiology, Public Health, Environmental and Occupational Health, Atrial fibrillation, Session (computer science), medicine.disease, business
Full Text
View/download PDF

55. PUK6 LOW-MOLECULAR-WEIGHT HEPARIN IN CHRONIC HEMODIALYSIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Author

Jean-Eric Tarride, C. von Keyserlingk, James M. Bowen, Wendy Lim, Mark Crowther, Ron Goeree, and Natasha Burke

Subjects
medicine.medical_specialty, medicine.drug_class, business.industry, Health Policy, Internal medicine, Meta-analysis, Public Health, Environmental and Occupational Health, medicine, Low molecular weight heparin, Chronic hemodialysis, business, Gastroenterology
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results